Home › Companies › ASTRIA THERAPEUTICS INC. › 2023-2024

ASTRIA THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ASTRIA THERAPEUTICS INC.’s Form 8-K, filed 2024-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Ballot items
  • 126Asset managers
  • 889Fund votes
  • 2024-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ASTRIA THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ASTRIA THERAPEUTICS INC.

These tallies are ASTRIA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ASTRIA THERAPEUTICS INC. — official shareholder meeting results, meeting held 2024-06-05
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Sunil Agarwal 46,212,531---- 23,7234,868,973 Majority: yes
Elect Director: Gregg Lapointe 38,546,969---- 7,366,6545,191,604 Majority: yes
Elect Director: Jonathan Violin 39,155,703---- 6,757,9205,191,604 Majority: yes
Proposal 2 . The stockholders of the Company approved the Second Amended and Restated 2015 Plan, to, among other things, increase the number of shares of common stock available for grant under the 2015 Plan by 5,750,000 shares, and extend t 33,617,01112,637,3812,586 --4,848,249 Majority: yes
Proposal 3 . The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. 51,069,77032,0613,396 ---- Majority: yes
Proposal 4 . The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers. 40,882,8885,346,9246,448 --4,868,967 Majority: yes

Source: ASTRIA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-06 — read the filing on EDGAR.

How asset managers voted at the ASTRIA THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 126 asset managers that disclosed a ASTRIA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 40,882,888AGAINST: 5,346,924

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 4 . The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers.”): 40,882,888 for, 5,346,924 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 124 asset managers below cast 91% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 91%9%
FOR: 90.9%AGAINST: 9.1%NOT VOTED: 0.0%
Largest asset managers voting on “THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION.” at ASTRIA THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity10,398,7840 00For
VR Adviser, LLC3,608,6450 00For
Fairmount Funds Management LLC3,554,1290 00For
PERCEPTIVE ADVISORS LLC3,535,8160 00For
State Street3,306,36647,223 00For
RA CAPITAL MANAGEMENT, L.P.3,308,3980 00For
BlackRock2,785,0218,490 00For
TCG Crossover Management, LLC2,761,8610 00For
Vanguard2,546,2490 00For
Vivo Capital, LLC2,329,0270 00For
Citadel1,599,1710 00For
Vestal Point Capital, LP01,250,000 00Against
DRIEHAUS CAPITAL MANAGEMENT LLC01,241,333 00Against
Logos Global Management LP1,119,9600 00For
GEODE CAPITAL MANAGEMENT, LLC999,1850 00For
Cormorant Asset Management, LP526,5700 00For
Avidity Partners Management LP500,8160 00For
Northern Trust417,8663,058 00For
Affinity Asset Advisors, LLC268,3000 00For
Charles Schwab262,1380 00For
DAFNA Capital Management LLC237,7640 00For
MELLON INVESTMENTS Corp207,7510 00For
Nuveen0207,197 00Against
TIAA0203,662 00Against
DRIEHAUS MUTUAL FUNDS0190,163 00Against

Showing the 25 largest of 124 asset managers. See all 124 in the interactive database.

2. The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the 2027 annual meeting of stockholders: Gregg Lapointe

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%
FOR: 38,546,969WITHHELD: 7,366,654

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Lapointe”): 38,546,969 for, 7,366,654 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 44 asset managers below cast 100% of the shares they voted on this item FOR (10,246,275 for, 0 against).

FOR 83%ABSTAIN 17%
FOR: 10,246,275 (83.2%)ABSTAIN: 2,067,045 (16.8%)
Largest asset managers voting on “The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the ” at ASTRIA THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,666,7780 00For
Vanguard2,452,9350 00For
BlackRock1,512,6340 00For
State Street13,7600 1,270,6950Abstain
TIAA203,6620 00For
DRIEHAUS MUTUAL FUNDS00 190,1630Abstain
Equitable85,2700 49,3700For
Direxion Shares ETF Trust00 132,5670Abstain
Charles Schwab131,0690 00For
RBB FUND, INC.00 104,0110Abstain
QUANTITATIVE MASTER SERIES LLC92,9110 00For
Brinker Capital Destinations Trust00 67,9730Abstain
Lincoln Financial00 39,6000Abstain
BRIDGEWAY FUNDS INC00 33,3010Abstain
Northern Trust00 31,8610Abstain
ProShares00 31,4760Abstain
AIG/SunAmerica00 24,5650Abstain
Pacific Life17,0860 00For
John Hancock00 17,0830Abstain
Voya15,7740 00For
Global X13,4950 00For
Bridge Builder Trust10,8490 00For
SEI10,8000 00For
Invesco9,7110 00For
Brighthouse00 9,6700Abstain

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

3. The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the 2027 annual meeting of stockholders: Jonathan Violin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 39,155,703WITHHELD: 6,757,920

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jonathan Violin”): 39,155,703 for, 6,757,920 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 44 asset managers below cast 100% of the shares they voted on this item FOR (10,327,506 for, 0 against).

FOR 84%ABSTAIN 16%
FOR: 10,327,506 (83.9%)ABSTAIN: 1,985,814 (16.1%)
Largest asset managers voting on “The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the ” at ASTRIA THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,666,7780 00For
Vanguard2,452,9350 00For
BlackRock1,512,6340 00For
State Street13,7600 1,270,6950Abstain
TIAA203,6620 00For
DRIEHAUS MUTUAL FUNDS00 190,1630Abstain
Equitable134,6400 00For
Direxion Shares ETF Trust00 132,5670Abstain
Charles Schwab131,0690 00For
RBB FUND, INC.00 104,0110Abstain
QUANTITATIVE MASTER SERIES LLC92,9110 00For
Brinker Capital Destinations Trust00 67,9730Abstain
Lincoln Financial00 39,6000Abstain
BRIDGEWAY FUNDS INC00 33,3010Abstain
Northern Trust31,8610 00For
ProShares00 31,4760Abstain
AIG/SunAmerica00 24,5650Abstain
Pacific Life17,0860 00For
John Hancock00 17,0830Abstain
Voya15,7740 00For
Global X13,4950 00For
Bridge Builder Trust10,8490 00For
SEI10,8000 00For
Invesco9,7110 00For
Brighthouse00 9,6700Abstain

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

4. The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the 2027 annual meeting of stockholders: Sunil Agarwal

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 46,212,531WITHHELD: 23,723

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sunil Agarwal”): 46,212,531 for, 23,723 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 44 asset managers below cast 100% of the shares they voted on this item FOR (12,313,320 for, 0 against).

FOR 100%
FOR: 12,313,320 (100.0%)
Largest asset managers voting on “The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the ” at ASTRIA THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,666,7780 00For
Vanguard2,452,9350 00For
BlackRock1,512,6340 00For
State Street1,284,4550 00For
TIAA203,6620 00For
DRIEHAUS MUTUAL FUNDS190,1630 00For
Equitable134,6400 00For
Direxion Shares ETF Trust132,5670 00For
Charles Schwab131,0690 00For
RBB FUND, INC.104,0110 00For
QUANTITATIVE MASTER SERIES LLC92,9110 00For
Brinker Capital Destinations Trust67,9730 00For
Lincoln Financial39,6000 00For
BRIDGEWAY FUNDS INC33,3010 00For
Northern Trust31,8610 00For
ProShares31,4760 00For
AIG/SunAmerica24,5650 00For
Pacific Life17,0860 00For
John Hancock17,0830 00For
Voya15,7740 00For
Global X13,4950 00For
Bridge Builder Trust10,8490 00For
SEI10,8000 00For
Invesco9,7110 00For
Brighthouse9,6700 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

5. THE APPROVAL OF THE SECOND AMENDMENT AND RESTATEMENT OF OUR AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, AS AMENDED, TO, AMONG OTHER THINGS, INCREASE THE NUMBER OF SHARES OF OUR COMMON STOCK AVAILABLE FOR GRANT UNDER THE PLAN BY 5,750,000 SHARES AND EXTEND THE TERM OF THE PLAN TO TEN YEARS FROM THE DATE SUCH SECOND AMENDMENT AND RESTATEMENT IS APPROVED BY OUR STOCKHOLDERS.

CAPITAL STRUCTUREMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%AGAINST 27%
FOR: 33,617,011AGAINST: 12,637,381

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 2 . The stockholders of the Company approved the Second Amended and Restated 2015 Plan, to, among other things, increase the number of shares of common stock available for grant under the 2015 Plan by 5,750,000 ”): 33,617,011 for, 12,637,381 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 44 asset managers below cast 43% of the shares they voted on this item FOR (5,292,537 for, 7,020,783 against).

FOR 43%AGAINST 57%
FOR: 5,292,537 (43.0%)AGAINST: 7,020,783 (57.0%)
Largest asset managers voting on “THE APPROVAL OF THE SECOND AMENDMENT AND RESTATEMENT OF OUR AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, AS” at ASTRIA THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity936,4044,730,374 00Against
Vanguard2,452,9350 00For
BlackRock1,512,6340 00For
State Street13,7601,270,695 00Against
TIAA0203,662 00Against
DRIEHAUS MUTUAL FUNDS0190,163 00Against
Equitable85,27049,370 00For
Direxion Shares ETF Trust0132,567 00Against
Charles Schwab131,0690 00For
RBB FUND, INC.0104,011 00Against
QUANTITATIVE MASTER SERIES LLC92,9110 00For
Brinker Capital Destinations Trust067,973 00Against
Lincoln Financial039,600 00Against
BRIDGEWAY FUNDS INC033,301 00Against
Northern Trust031,861 00Against
ProShares031,476 00Against
AIG/SunAmerica024,565 00Against
Pacific Life17,0860 00For
John Hancock017,083 00Against
Voya015,774 00Against
Global X13,4950 00For
Bridge Builder Trust10,8490 00For
SEI10,8000 00For
Invesco9,7110 00For
Brighthouse09,670 00Against

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

6. THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 51,069,770AGAINST: 32,061

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 3 . The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 51,069,770 for, 32,061 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 44 asset managers below cast 99.9% of the shares they voted on this item FOR (12,311,134 for, 2,186 against).

FOR 99.9%
FOR: 12,311,134 (100.0%)AGAINST: 2,186 (0.0%)
Largest asset managers voting on “THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at ASTRIA THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,666,7780 00For
Vanguard2,452,9350 00For
BlackRock1,512,6340 00For
State Street1,282,2692,186 00For
TIAA203,6620 00For
DRIEHAUS MUTUAL FUNDS190,1630 00For
Equitable134,6400 00For
Direxion Shares ETF Trust132,5670 00For
Charles Schwab131,0690 00For
RBB FUND, INC.104,0110 00For
QUANTITATIVE MASTER SERIES LLC92,9110 00For
Brinker Capital Destinations Trust67,9730 00For
Lincoln Financial39,6000 00For
BRIDGEWAY FUNDS INC33,3010 00For
Northern Trust31,8610 00For
ProShares31,4760 00For
AIG/SunAmerica24,5650 00For
Pacific Life17,0860 00For
John Hancock17,0830 00For
Voya15,7740 00For
Global X13,4950 00For
Bridge Builder Trust10,8490 00For
SEI10,8000 00For
Invesco9,7110 00For
Brighthouse9,6700 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Largest ASTRIA THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked by the number of ASTRIA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting.

Top ASTRIA THERAPEUTICS INC. shareholders by shares voted, 2023-2024
#Asset manager Shares voted
1Fidelity 10,398,784
2VR Adviser, LLC 3,608,645
3Fairmount Funds Management LLC 3,554,129
4PERCEPTIVE ADVISORS LLC 3,535,816
5State Street 3,353,589
6RA CAPITAL MANAGEMENT, L.P. 3,308,398
7BlackRock 2,793,511
8TCG Crossover Management, LLC 2,761,861
9Vanguard 2,546,249
10Vivo Capital, LLC 2,329,027

Shown as share counts, not percentages: no shares-outstanding figure has been matched to ASTRIA THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ASTRIA THERAPEUTICS INC.'s shareholder meeting held 2024-06-05, in the 2023-2024 proxy season, 126 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 889 separate fund positions. On the most widely held item on that ballot — THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION. — FOR was 88% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ASTRIA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-06.

ASTRIA THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.